Investor insights
Sectors invested in
Funding rounds participated in
$18M sweet spot round size
Most of their 29 investments are in rounds between $10M and $25M
Basic info
Industry
Sectors
Date founded
2000
Investments made
VERALOX Therapeutics raised $24M on June 20, 2023
Investors: Sanofi Ventures, JDRF T1D Fund, Pappas Capital, NYBC Ventures and Genesys Capital
Inversago Pharma Inc raised $69M on October 17, 2022
Investors: adMare BioInnovations, Forbion, JDRF T1D Fund and Genesys Capital
VERALOX Therapeutics raised $17M on June 16, 2021
Investors: Sanofi Ventures, Point Field Partners, VTC Innovation Fund, JDRF T1D Fund, Maryland Momentum Fund, Alumni Ventures Group and Genesys Capital
giiant pharma Inc. raised $12M on May 21, 2021
Investors: Anges Québec, AQC Capital, CQDM - Enabling Drug Discovery/Accélérer la découverte du médicament, Theodorus Investment Funds, Amplitude Ventures and Genesys Capital
Flosonics Medical raised $14M on February 2, 2021
Investors: iGan Partners and Genesys Capital
Inversago Pharma Inc raised $35M on September 8, 2020
Investors: adMare BioInnovations, AQC Capital, JDRF T1D Fund, Forbion and Genesys Capital
IDbyDNA raised $20M on January 29, 2020
Investors: ARTIS Ventures, Sand Hill Angels and Genesys Capital
Inversago Pharma Inc raised $7M on July 25, 2018
Investors: Anges Québec, Tarnagulla Ventures, Accel-Rx - Canada's Health Science Accelerator, JDRF T1D Fund, AQC Capital and Genesys Capital
Flosonics Medical raised $5M on January 29, 2018
Investors: Accel-Rx - Canada's Health Science Accelerator, Angel One Investor Network, iGan Partners, Amplify Capital (formerly MaRS Catalyst Fund), MaRS Investment Accelerator Fund and Genesys Capital
Adapsyn Bioscience raised undisclosed on January 11, 2018
Investors: Genesys Capital